Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and selective reporting. The extra effort is worth it.
Publishing an inconvenient result: a case study posts 61–71
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
This follows post #60 rather than contradicting it.
PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over time rather than at a point in time.
Collapsed as off-topic by two members at trust level 3 or above
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
On post #62 — agreed on the reasoning, with one qualification.
When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It means the documents did not contain enough to check.
Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.
Collapsed as off-topic by two members at trust level 3 or above
post #68 is right about the mechanism and I think understates the practical bit.
Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth more than self-selected ones.
Worth separating two things that post #66 runs together.
How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly ensures results are interpretable.
Coming back to post #69, because the follow-up matters more than the original answer.
Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is usually faster than testing.
This topic was referenced in
- Submitting a sample: the process end to endSourcing › Independent verification · 114 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What a documentation review can and cannot tell you — a second dataset
The question in the title: What a documentation review can and cannot tell you — a second dataset I will give what I have already checked below so nobody repeats it. I would like to talk about documentation…
|
4 | 170 | 4mo | |
|
Choosing which test to pay for, given a fixed budget
On the subject in the title: Choosing which test to pay for, given a fixed budget Working notes rather than a conclusion. I would like to talk about documentation quality as a signal, separately from product…
|
+60 | 70 | 49k | 3mo |
|
Aggregate verification data across the directory, with caveats
On the subject in the title: Aggregate verification data across the directory, with caveats Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+64 | 74 | 4.6k | 14h |
|
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the…
|
+42 | 46 | 46k | 2mo |
|
[2026 update] What a purity-only report leaves out
The question in the title: What a purity-only report leaves out I will give what I have already checked below so nobody repeats it. Structured report rather than an opinion, following the format the…
|
+97 | 103 | 5.2k | 3mo |
Related topics — sharing the tags Medutest, VendorInvestigate, third-party testing
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What a purity-only report leaves out
What a purity-only report leaves out — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
|
+92 | 105 | 4k | 8mo |
|
Documenting a supplier's response to a discrepancy
On the subject in the title: Documenting a supplier's response to a discrepancy Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers asked…
|
+44 | 49 | 589 | 8h |
|
Coming back to: What consumer-accessible tests can and cannot determine
Asking directly, because I could not find a straight answer: What consumer-accessible tests can and cannot determine Posting the method first, because I know what the first three replies will otherwise be.…
|
+4 | 8 | 25k | 22mo |
|
A comparison of home results against a laboratory result on the same vial
Posting this under the heading it deserves: A comparison of home results against a laboratory result on the same vial Everything below is what sits behind that. Working through the identity arithmetic and I…
|
+61 | 65 | 35k | 8mo |
|
A comparison of home results against a laboratory result on the same vial — does this still hold?
A comparison of home results against a laboratory result on the same vial — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Working through the…
|
+2 | 6 | 15k | 11h |